U.S. Firm Sues Sun Pharma for ‘Patent Infringement’

U.S.-based Medpointe Healthcare Inc has sued India’s Sun Pharmaceuticals in a U.S. court in late June for alleged patent infringement of its anti-allergic ophthalmic drug, Optivar.
Financial Express